Toll Free: 1-888-928-9744

United States Glaucoma Therapeutics Devices Sales Market Report 2021

Published: Aug 2, 2016 | Pages: 122 | Publisher: QYResearch | Industry: Medical Devices | Report Format: Electronic (PDF)

This report studies sales (consumption) of Glaucoma Therapeutics Devices in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
    Allergan Inc.
    Merck & Co. Inc.
    Novartis AG
    Pfizer Inc.
    Acadia Pharmaceuticals Inc.
    AC Immune SA
    Acorn Biomedical Inc.
    Advanced Cell Technology Inc.
    Aerie Pharmaceuticals Inc.
    Carl Zeiss Meditec Inc.
    Falcon Pharmaceuticals Ltd.
    Inotek Pharmaceuticals Corp.
    Lexicon Pharmaceuticals Inc.
    Neurotech Pharmaceuticals Inc.
    NicOx SA
    Otsuka Holdings Co. Ltd.
    Phytopharm plc
    Santen Pharmaceuticals Co. Ltd.
    Senju Pharmaceutical Co. Ltd.
    SIFI SpA
    Valeant Pharmaceuticals International Inc.

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
    Prostaglandins
    Beta Blockers
    Alpha Adrenergic Agonists
    Carbonic Anhydrase Inhibitors
    Fixed Dose Combinations
Split by applications, this report focuses on sales, market share and growth rate of  Glaucoma Therapeutics Devices in each application, can be divided into
    Application 1
    Application 2
    Application 3

 Table of Contents
United States Glaucoma Therapeutics Devices Sales Market Report 2021 1 Glaucoma Therapeutics Devices Overview 1.1 Product Overview and Scope of Glaucoma Therapeutics Devices 1.2 Classification of Glaucoma Therapeutics Devices 1.2.1 Prostaglandins 1.2.2 Beta Blockers 1.2.3 Alpha Adrenergic Agonists 1.2.4 Carbonic Anhydrase Inhibitors 1.2.5 Fixed Dose Combinations 1.3 Applications of Glaucoma Therapeutics Devices 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 USA Market Size (Value and Volume) of Glaucoma Therapeutics Devices (2011-2021) 1.4.1 USA Glaucoma Therapeutics Devices Sales, Revenue and Price (2011-2021) 1.4.2 USA Glaucoma Therapeutics Devices Sales and Growth Rate (2011-2021) 1.4.3 USA Glaucoma Therapeutics Devices Revenue and Growth Rate (2011-2021) 2 USA Glaucoma Therapeutics Devices Competition by Manufacturers 2.1 USA Glaucoma Therapeutics Devices Sales and Market Share of Key Manufacturers (2015 and 2016) 2.2 USA Glaucoma Therapeutics Devices Revenue and Share by Manufactures (2015 and 2016) 3 USA Glaucoma Therapeutics Devices (Volume and Value) by Type 3.1 USA Glaucoma Therapeutics Devices Sales and Market Share by Type (2011-2021) 3.2 USA Glaucoma Therapeutics Devices Revenue and Market Share by Type (2011-2021) 4 USA Glaucoma Therapeutics Devices (Volume) by Application 5 USA Glaucoma Therapeutics Devices Manufacturers Analysis 5.1 Allergan Inc. 5.1.1 Company Basic Information, Manufacturing Base and Competitors 5.1.2 Glaucoma Therapeutics Devices Product Type and Technology 5.1.2.1 Prostaglandins 5.1.2.2 Beta Blockers 5.1.3 Glaucoma Therapeutics Devices Sales, Revenue, Price of Allergan Inc. (2015 and 2016) 5.2 Merck & Co. Inc. 5.2.1 Company Basic Information,Manufacturing Base and Competitors 5.2.2 Medical Devices Product Type and Technology 5.2.2.1 Prostaglandins 5.2.2.2 Beta Blockers 5.2.3 Medical Devices Sales, Revenue, Price of Merck & Co. Inc. (2015 and 2016) 5.3 Novartis AG 5.3.1 Company Basic Information,Manufacturing Base and Competitors 5.3.2 Novartis AG Product Type and Technology 5.3.2.1 Prostaglandins 5.3.2.2 Beta Blockers 5.3.3 Novartis AG Sales, Revenue, Price of Novartis AG (2015 and 2016) 5.4 Pfizer Inc. 5.4.1 Company Basic Information,Manufacturing Base and Competitors 5.4.2 Aerie Pharmaceuticals Inc. Product Type and Technology 5.4.2.1 Prostaglandins 5.4.2.2 Beta Blockers 5.4.3 Pfizer Inc. Sales, Revenue, Price of Pfizer Inc. (2015 and 2016) 5.5 Acadia Pharmaceuticals Inc. 5.5.1 Company Basic Information,Manufacturing Base and Competitors 5.5.2 Acadia Pharmaceuticals Inc. Product Type and Technology 5.5.2.1 Prostaglandins 5.5.2.2 Beta Blockers 5.5.3 Acadia Pharmaceuticals Inc. Sales, Revenue, Price of Acadia Pharmaceuticals Inc. (2015 and 2016) 5.6 AC Immune SA 5.6.1 Company Basic Information,Manufacturing Base and Competitors 5.6.2 AC Immune SA Product Type and Technology 5.6.2.1 Prostaglandins 5.6.2.2 Beta Blockers 5.6.3 AC Immune SA Sales, Revenue, Price of AC Immune SA (2015 and 2016) 5.7 Acorn Biomedical Inc. 5.7.1 Company Basic Information,Manufacturing Base and Competitors 5.7.2 Acorn Biomedical Inc. Product Type and Technology 5.7.2.1 Prostaglandins 5.7.2.2 Beta Blockers 5.7.3 Acorn Biomedical Inc. Sales, Revenue, Price of Acorn Biomedical Inc. (2015 and 2016) 5.8 Advanced Cell Technology Inc. 5.8.1 Company Basic Information,Manufacturing Base and Competitors 5.8.2 Advanced Cell Technology Inc. Product Type and Technology 5.8.2.1 Prostaglandins 5.8.2.2 Beta Blockers 5.8.3 Advanced Cell Technology Inc. Sales, Revenue, Price of Advanced Cell Technology Inc. (2015 and 2016) 5.9 Aerie Pharmaceuticals Inc. 5.9.1 Company Basic Information,Manufacturing Base and Competitors 5.9.2 Aerie Pharmaceuticals Inc. Product Type and Technology 5.9.2.1 Prostaglandins 5.9.2.2 Beta Blockers 5.9.3 Aerie Pharmaceuticals Inc. Sales, Revenue, Price of Aerie Pharmaceuticals Inc. (2015 and 2016) 5.10 Carl Zeiss Meditec Inc. 5.10.1 Company Basic Information,Manufacturing Base and Competitors 5.10.2 Carl Zeiss Meditec Inc. Product Type and Technology 5.10.2.1 Prostaglandins 5.10.2.2 Beta Blockers 5.10.3 Carl Zeiss Meditec Inc. Sales, Revenue, Price of Carl Zeiss Meditec Inc. (2015 and 2016) 5.11 Falcon Pharmaceuticals Ltd. 5.12 Inotek Pharmaceuticals Corp. 5.13 Lexicon Pharmaceuticals Inc. 5.14 Neurotech Pharmaceuticals Inc. 5.15 NicOx SA 5.16 Otsuka Holdings Co. Ltd. 5.17 Phytopharm plc 5.18 Santen Pharmaceuticals Co. Ltd. 5.19 Senju Pharmaceutical Co. Ltd. 5.20 SIFI SpA 5.21 Valeant Pharmaceuticals International Inc. 6 Glaucoma Therapeutics Devices Technology and Development Trend 6.1 Glaucoma Therapeutics Devices Technology Analysis 6.2 Glaucoma Therapeutics Devices Technology Development Trend 7 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Glaucoma Therapeutics Devices Table Classification of Glaucoma Therapeutics Devices Figure USA Sales Market Share of Glaucoma Therapeutics Devices by Type in 2015 Figure Prostaglandins Picture Figure Beta Blockers Picture Figure Alpha Adrenergic Agonists Picture Figure Carbonic Anhydrase Inhibitors Picture Figure Fixed Dose Combinations Picture Table Applications of Glaucoma Therapeutics Devices Figure USA Sales Market Share of Glaucoma Therapeutics Devices by Application in 2015 Table USA Glaucoma Therapeutics Devices Sales, Revenue and Price (2011-2021) Figure USA Glaucoma Therapeutics Devices Sales and Growth Rate (2011-2021) Figure USA Glaucoma Therapeutics Devices Revenue and Growth Rate (2011-2021) Table USA Glaucoma Therapeutics Devices Sales of Key Manufacturers (2015 and 2016) Table USA Glaucoma Therapeutics Devices Sales Share by Manufacturers (2015 and 2016) Figure 2015 Glaucoma Therapeutics Devices Sales Share by Manufacturers Figure 2016 Glaucoma Therapeutics Devices Sales Share by Manufacturers Table USA Glaucoma Therapeutics Devices Revenue by Manufacturers (2015 and 2016) Table USA Glaucoma Therapeutics Devices Revenue Share by Manufacturers (2015 and 2016) Table 2015 USA Glaucoma Therapeutics Devices Revenue Share by Manufacturers Table 2016 USA Glaucoma Therapeutics Devices Revenue Share by Manufacturers Table USA Glaucoma Therapeutics Devices Sales and Market Share by Type (2011-2021) Table USA Glaucoma Therapeutics Devices Sales Share by Type (2011-2021) Figure Sales Market Share of Glaucoma Therapeutics Devices by Type (2011-2021) Figure USA Glaucoma Therapeutics Devices Sales Growth Rate by Type (2011-2021) Table USA Glaucoma Therapeutics Devices Revenue and Market Share by Type (2011-2021) Table USA Glaucoma Therapeutics Devices Revenue Share by Type (2011-2021) Figure Revenue Market Share of Glaucoma Therapeutics Devices by Type (2011-2021) Figure USA Glaucoma Therapeutics Devices Revenue Growth Rate by Type (2011-2021) Table USA Glaucoma Therapeutics Devices Sales and Market Share by Application (2011-2021) Table USA Glaucoma Therapeutics Devices Sales Share by Application (2011-2021) Figure Sales Market Share of Glaucoma Therapeutics Devices by Application (2011-2021) Figure USA Glaucoma Therapeutics Devices Sales Growth Rate by Application (2011-2021) Table Allergan Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Allergan Inc. (2015 and 2016) Table Merck & Co. Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Merck & Co. Inc. (2015 and 2016) Table Novartis AG Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Novartis AG (2015 and 2016) Table Pfizer Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Pfizer Inc. (2015 and 2016) Table Acadia Pharmaceuticals Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Acadia Pharmaceuticals Inc. (2015 and 2016) Table AC Immune SA Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of AC Immune SA (2015 and 2016) Table Acorn Biomedical Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Acorn Biomedical Inc. (2015 and 2016) Table Advanced Cell Technology Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Advanced Cell Technology Inc. (2015 and 2016) Table Aerie Pharmaceuticals Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Aerie Pharmaceuticals Inc. (2015 and 2016) Table Carl Zeiss Meditec Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Carl Zeiss Meditec Inc. (2015 and 2016) Table Falcon Pharmaceuticals Ltd. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Falcon Pharmaceuticals Ltd. (2015 and 2016) Table Inotek Pharmaceuticals Corp. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Inotek Pharmaceuticals Corp. (2015 and 2016) Table Lexicon Pharmaceuticals Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Lexicon Pharmaceuticals Inc. (2015 and 2016) Table Neurotech Pharmaceuticals Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Neurotech Pharmaceuticals Inc. (2015 and 2016) Table NicOx SA Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of NicOx SA (2015 and 2016) Table Otsuka Holdings Co. Ltd. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Otsuka Holdings Co. Ltd. (2015 and 2016) Table Phytopharm plc Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Phytopharm plc (2015 and 2016) Table Santen Pharmaceuticals Co. Ltd. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Santen Pharmaceuticals Co. Ltd. (2015 and 2016) Table Senju Pharmaceutical Co. Ltd. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Senju Pharmaceutical Co. Ltd. (2015 and 2016) Table SIFI SpA Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of SIFI SpA (2015 and 2016) Table Valeant Pharmaceuticals International Inc. Basic Information List Table Glaucoma Therapeutics Devices Sales, Revenue, Price of Valeant Pharmaceuticals International Inc. (2015 and 2016)



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...

Global air traffic control equipment market is projected to reach USD 4.2 billion by 2020, as per a new research report by Radiant Insights, Inc. Mounting price sensitivity among customers with introduction of low fare airlines is expected to drive t

Read More...

Global FPGA market is anticipated to be valued at USD 9,882.5 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing demand for customized IC’s is expected to drive the demand. Customized IC’s helps manufacturers to mo

Read More...

Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing ap

Read More...

Global engineering service outsourcing market size is likely to be valued at USD 415.7 billion by 2020, as per a new research report by Radiant Insights, Inc. Rapid alignment of OEMs accompanied by increasing focus on efficient performance and reliab

Read More...
Choose License Type
Single User - US $3800
Multi User - US $4940
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify